Zydus Responds to Delhi HC Drug Supply Restriction

Key Event: Court Order

A news item reported that the Hon'ble Delhi High Court passed an order to temporarily restrict the Company's supply of the cancer drug IkraTM.

Materiality Assessment and Regulatory Compliance

The company states that:

• There are no negotiations or events requiring disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
• The court order event is not material as per the company's materiality policy and the provisions of the Listing Regulations.
• There was no material movement in the trading of the company's equity shares on July 14, 2026, due to the news.
• The company believes there is no material impact from this event.

Commitment

The company reaffirms its commitment to comply with all applicable disclosure requirements under the Listing Regulations and to keep the stock exchanges informed of any material developments as required.